This list is an analysis based on recent market events. It's not an investment recommendation.
About
Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.
The current price of MAZE.BOATS is $30.17 USD — it has decreased by -7.03% in the past 24 hours. Watch Maze Therapeutics stock price performance more closely on the chart.
What is Maze Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange Maze Therapeutics stocks are traded under the ticker MAZE.BOATS.
What is Maze Therapeutics market cap?▼
Today Maze Therapeutics has the market capitalization of 1.68B
When is the next Maze Therapeutics earnings date?▼
Maze Therapeutics is going to release the next earnings report on November 5, 2026.
What were Maze Therapeutics earnings last quarter?▼
MAZE.BOATS earnings for the last quarter are -0.76 USD per share, whereas the estimation was -0.72 USD resulting in a -5.95% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Maze Therapeutics revenue for the last year?▼
Maze Therapeutics revenue for the last year amounts to 0 USD.
What is Maze Therapeutics net income for the last year?▼
MAZE.BOATS net income for the last year is -131.12M USD.
In which sector is Maze Therapeutics located?▼
Maze Therapeutics operates in the Other sector.
When did Maze Therapeutics complete a stock split?▼
Maze Therapeutics has not had any recent stock splits.